RECENT REAL-WORLD TRENDS IN MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) BY US COMMUNITY RHEUMATOLOGISTS

被引：0
|
作者：
Radtchenko, J. [1 ]
Pallett, P. [1 ]
Stockton, C. M. [1 ]
Feinberg, B. A. [1 ]
机构：
[1] Cardinal Hlth, Dublin, OH USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1772
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY131
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [31] Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
    Bai, Wei
    Li, Mengtao
    Zhou, Shuang
    Peng, Liying
    Zhao, Jiuliang
    Tian, Xinping
    Wang, Qian
    Leng, Xiaomei
    Zhang, Shangzhu
    Wang, Yanhong
    Zhao, Yan
    Zeng, Xiaofeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (18) : 2245 - 2247
  • [32] Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study
    Wang, D. -D.
    Lu, J. -M.
    Li, Q.
    Li, Z. -P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (04) : 476 - 483
  • [33] Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
    Bai Wei
    Li Mengtao
    Zhou Shuang
    Peng Liying
    Zhao Jiuliang
    Tian Xinping
    Wang Qian
    Leng Xiaomei
    Zhang Shangzhu
    Wang Yanhong
    Zhao Yan
    Zeng Xiaofeng
    中华医学杂志(英文版), 2022, 135 (18)
  • [34] Anifrolumab in Systemic Lupus Erythematosus: Real World Experience
    Jalali, Kafaf
    Legault, Kimberly
    Matsos, Mark
    Tselios, Konstantinos
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 64 - 65
  • [35] Satisfaction and Impact Associated with the Addition of Belimumab to Systemic Lupus Erythematosus (SLE) Treatment: A Cross-Sectional Survey of US Rheumatologists and Their Patients
    Pascoe, Katie
    Lobosco, Steve
    Bell, David
    Hoskin, Ben
    Ramachandran, Sulabha
    Pobiner, Bonnie
    Chang, David
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] Real World Experience with Belimumab in the Management of Systemic Lupus Erythematosus (SLE): A Single Center, Observational, Post-Marketing Study.
    Kim, Susan S.
    Pavri, Tanya
    Kirou, Kyriakos A.
    Salmon, Jane
    Erkan, Doruk
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S951 - S951
  • [37] Trends in the incidence and mortality of systemic lupus erythematosus (SLE) - 1950-92.
    Uramoto, KM
    Michet, CJ
    Thumboo, J
    Sunku, J
    OFallon, M
    Gabriel, SE
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 781 - 781
  • [38] EPIDEMIOLOGICAL DISEASE BURDEN AND COST OF ILLNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN THE US
    Chopra, A.
    Bhalani, S.
    Jabin, F.
    Gaur, A.
    Kukreja, I
    Roy, A.
    Gupta, A.
    Brooks, L.
    Sulzicki, M.
    Verma, V.
    Pandey, S.
    Field, S.
    Krebs, B.
    VALUE IN HEALTH, 2022, 25 (07) : S448 - S448
  • [39] CLUSTER PROFILING OF PATIENTS IN A REAL-WORLD DATA SET WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR ASSOCIATED TREATMENTS
    Touma, Zahi
    Hoskin, Ben
    Atkinson, Christian
    Bell, David
    Massey, Olivia
    Lofland, Jennifer H.
    Berry, Pam
    Karyekar, Chetan
    Costenbader, Karen
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 763 - 763
  • [40] Correlation between neuropsychiatric systemic lupus erythematosus and immunological markers: a real-world retrospective study
    Jiang, Yutong
    Yuan, Fei
    Xu, Xinyuan
    Liu, Yuhong
    Liang, Yao
    Zhang, Yanli
    Lin, Zhiming
    Zhao, Changlin
    CLINICAL RHEUMATOLOGY, 2024, 43 (09) : 2833 - 2842
12345